Hologic has acquired Reveal Genomics, a Catalan biotech dedicated to breast cancer testing, which was founded as a spin-off from the University of Barcelona and associated hospitals, with a team of 19 employees who will join Hologic after the completion of the operation. #Hologic #RevealGenomics #CáncerDeMama (translated)
www.lavanguardia.com
Hologic adquiere Reveal Genomics, una 'biotech' catalana de tests de cáncer de mama
